Eton Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Eton Pharmaceuticals (ETON).

Price Target Range — 10 Quarters

Analyst Consensus — 4 Analysts

4Buy

Consensus RatingBuy# Analysts4Avg. Consensus PT$56Upside to Avg. PT+14.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 14, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$70
Aug 14, 2026	Canaccord Genuity	Gary Nachman	PT Raise	Buy	$60→$68
Aug 14, 2026	B. Riley Securities	Madison El-Saadi	PT Raise	Buy	$40→$70
Aug 14, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$65→$70
Aug 11, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$57→$65
Jul 28, 2026	Craig-Hallum	Chase Knickerbocker	PT Raise	Buy	$40→$62
Jul 17, 2026	Canaccord Genuity	Gary Nachman	Initiate	Buy	$60
May 15, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$52→$57
Mar 20, 2026	B. Riley Securities	Madison El-Saadi	PT Raise	Buy	$26→$31
Mar 20, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$37→$52
Mar 20, 2026	Craig-Hallum	Chase Knickerbocker	PT Raise	Buy	$30→$35
Mar 3, 2026	Craig-Hallum	Chase Knickerbocker	PT Raise	Buy	$29→$30
Mar 2, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$35→$37
May 29, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$33→$35
May 16, 2025	B. Riley Securities	Madison El-Saadi	PT Raise	Buy	$24→$26
May 14, 2025	Craig-Hallum	Chase Knickerbocker	PT Raise	Buy	$26→$28
Mar 19, 2025	Craig-Hallum	Chase Knickerbocker	PT Raise	Buy	$23→$26
Mar 19, 2025	B. Riley Securities	Madison El-Saadi	PT Raise	Buy	$21→$24
Mar 19, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$33
Jan 23, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$17→$33

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $70 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and maintains $70 price target.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $68

Canaccord Genuity analyst Gary Nachman maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $60 to $68.

Benzinga Newsdesk

PRO
B. Riley Securities Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $70

B. Riley Securities analyst Madison El-Saadi reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $40 to $70.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $70

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $65 to $70.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $65

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $57 to $65.

Benzinga Newsdesk

PRO
Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $62

Craig-Hallum analyst Chase Knickerbocker maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $40 to $62.

Benzinga Newsdesk

Eton Pharmaceuticals Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Eton Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $70 Price Target

PRO
Canaccord Genuity Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $68

PRO
B. Riley Securities Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $70

PRO
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $70

PRO
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $65

PRO
Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $62

People Also Watch

People Also Watch

Eton Pharmaceuticals Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Eton Pharmaceuticals Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $70 Price Target

PROCanaccord Genuity Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $68

PROB. Riley Securities Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $70

PROHC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $70

PROHC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $65

PROCraig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $62

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $70 Price Target

PRO
Canaccord Genuity Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $68

PRO
B. Riley Securities Reiterates Buy on Eton Pharmaceuticals, Raises Price Target to $70

PRO
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $70

PRO
HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $65

PRO
Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $62